Anti-tumor effects of gCpG based vaccine were partially reduced as the lack of CD4+ T cells, while depletion of CD8+ T abrogated the anti-tumor efficacy of the vaccine (Fig. 5a), indicating that gCpG based vaccine controlled tumor growth by CD8+ T cells. This evidence concerns the gene CD4 and neoplasm.